RUBIN, TURNBULL & ASSOCIATES

RUBIN, TURNBULL & ASSOCIATES filed a Q2 termination report for USANTIBIOTICS on July 18, 2026, reporting $90,000 in lobbying income.

Lobbying for USANTIBIOTICS · Pharmaceutical manufacturer

Filing · LD-2 quarterly report Q2 termination

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 18, 2026

Income

$90,000

What the client paid this registrant for the period.

Client based in

Tennessee

Representation ended

Jun 30, 2026

The registrant reported terminating its work for this client.

Lobbying activity 1

Advocate on issues related to pharmaceuticals and drug regulation.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.